Argitalpenak (38) MARIA ROSA SANABRIA RUIZ COLMENARES argitalpenak

2023

  1. Impact of COVID-19 Confinement on Quality of Life of Patients with Age-Related Macular Degeneration: A Two-Wave Panel Study

    Journal of Clinical Medicine, Vol. 12, Núm. 6

2022

  1. Depósitos prerretinianos tipo estalagmita en la tomografía de coherencia óptica de dos pacientes vitrectomizados con panuveítis

    Archivos de la Sociedad Española de Oftalmologia, Vol. 97, Núm. 2, pp. 104-108

  2. Modifiable Determinants of Satisfaction with Intravitreal Treatment in Patients with Neovascular Age-Related Macular Degeneration

    Drugs and Aging, Vol. 39, Núm. 5, pp. 355-366

  3. Pathophysiology of Age-Related Macular Degeneration: Implications for Treatment

    Ophthalmic Research, Vol. 65, Núm. 6, pp. 615-636

2021

  1. Letter To The Editor: Multiple Large Preretinal Hemorrhages In The Context Of Severe Acute Respiratory Syndrome Coronavirus 2 Infection

    Arquivos Brasileiros de Oftalmologia, Vol. 84, Núm. 6, pp. 628-629

  2. Progression of myopic maculopathy in a Caucasian cohort of highly myopic patients with long follow-up: a multistate analysis

    Graefe's Archive for Clinical and Experimental Ophthalmology, Vol. 259, Núm. 1, pp. 81-92

  3. Silicone microbubbles after anti-vascular endothelial growth factor injections in patients with wet age-related macular degeneration: incidence, quantification and secondary optical coherence tomography artfacts

    Acta Ophthalmologica, Vol. 99, Núm. 7, pp. e1051-e1055

2018

  1. Fluorescein angiography indications: Changes after optical coherence tomography and antiangiogenics

    Optometry and Vision Science, Vol. 95, Núm. 5, pp. 435-442

2017

  1. Predictive models of long-term anatomic outcome in age-related macular degeneration treated with as-needed Ranibizumab

    BMC Ophthalmology, Vol. 17, Núm. 1

2015

  1. Loss of Visual Acuity after Successful Surgery for Macula-On Rhegmatogenous Retinal Detachment in a Prospective Multicentre Study

    Journal of Ophthalmology, Vol. 2015

  2. Role of Systemic Anti-Tumor Necrosis Factor Alpha Treatment in the Reduction of Proliferative Vitreoretinopathy

    Journal of Clinical & Experimental Ophthalmology, Vol. 06, Núm. 04

2013

  1. A new manual retinal thickness measurement protocol to evaluate high myopia patients

    Ophthalmologica, Vol. 230, Núm. 3, pp. 121-125

  2. Autofluorescence images with carl zeiss versus topcon eye fundus camera: A comparative study

    Journal of Ophthalmology, Vol. 2013

  3. External validation of existing formulas to predict the risk of developing proliferative vitreoretinopathy: The retina 1 project; Report 5

    Retina, Vol. 33, Núm. 8, pp. 1519-1527

  4. General practitioners’ knowledge gaps regarding age related macular degeneration and effectiveness of their e-learning training

    Journal of Hospital Administration, Vol. 2, Núm. 4, pp. 37

  5. Ocular pain after intravitreal injection

    Current Eye Research, Vol. 38, Núm. 2, pp. 278-282

2012

  1. A propensity score matching application: Indications and results of adding scleral buckle to vitrectomy: The Retina 1 project: Report 3

    European Journal of Ophthalmology, Vol. 22, Núm. 2, pp. 244-253

  2. E-learning strategies to improve general practitioners' knowledge of age-related macular degeneration

    Medical Education

  3. Pathology associated with optical coherence tomography macular bending due to either dome-shaped macula or inferior staphyloma in myopic patients

    Ophthalmologica, Vol. 228, Núm. 1, pp. 7-12

  4. Retinal pigment epithelium tears in age-related macular degeneration treated with antiangiogenic drugs: A controlled study with long follow-up

    Ophthalmologica, Vol. 228, Núm. 2, pp. 78-83